Effects of suppository of a drug based on Persian medicine (Damask rose) in vaginal fungal infection

Effects of suppository of a drug based on Persian medicine (Rosa damascena Mill.) in vulvovaginal candidiasis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171112037414N1

Enrollment

Registered

2017-12-11

Start date

2018-01-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vulvovaginal candidiasis. Candidiasis of vulva and vagina

Interventions

Each patient randomly receives one vaginal suppository of rosa or vaginal suppository of placebo every night for one week..

Treatment - Drugs

Each patient randomly receives one vaginal suppository of rosa or vaginal suppository of placebo every night for one week.

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clinical features of candidiasis. Timepoint: Before the intervention, one week after the intervention, 37 days after the intervention. Method of measurement: visual analogue scale.	—

Secondary

Measure	Time frame
Side effects of drug. Timepoint: One week and 37 days after the intervention. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomayyeh Khalilzadeh

Tehran University of Medical Sciences

s-khalilzadeh@razi.tums.ac.ir+98 21 8897 6527

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026